| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across the United States. Its flagship therapeutic candidate, KIO-301, is a groundbreaking small molecule undergoing Phase 1 clinical trials. This innovative "photoswitch" aims to revitalize vision in individuals suffering from both inherited and age-related forms of retinal degeneration. The company's pipeline also includes KIO-101, an eye drop currently …
Over the last 12 months, insiders at Kiora Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Kiora Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Kiora Pharmaceuticals, Inc. have bought $60,189 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,250 shares for transaction amount of $4,600 was made by Stengone Carmine N. (director) on 2024‑09‑11.
| 2024-09-11 | Stengone Carmine N. | director | 1,250 0.0442% | $3.68 | $4,600 | -9.22% | ||
| 2024-09-10 | Shapiro Aron | director | 3,000 0.1039% | $3.60 | $10,800 | -7.14% | ||
| 2024-08-19 | TYLE PRAVEEN | director | 5,000 0.165% | $3.96 | $19,800 | -18.56% | ||
| 2024-08-19 | Walters-Hoffert Lisa | director | 1,250 0.0402% | $3.86 | $4,825 | -18.56% | ||
| 2024-08-14 | Tosca Melissa | CFO | 2,000 0.0667% | $3.21 | $6,420 | +6.29% | ||
| 2024-06-14 | Daniels Eric Joseph | Chief Development Officer | 1,431 0.0556% | $5.29 | $7,570 | -35.63% | ||
| 2024-06-14 | Tosca Melissa | EVP Finance | 100 0.0039% | $5.25 | $525 | -35.63% | ||
| 2024-06-13 | Strem Brian M. | President and CEO | 3,000 0.1101% | $5.00 | $14,997 | -28.72% | ||
| 2024-06-13 | Parsons Erin | director | 5,260 0.1885% | $4.88 | $25,669 | -28.72% | ||
| 2021-11-18 | Strem Brian M. | President and CEO | 17,853 0.1764% | $1.41 | $25,173 | -68.88% | ||
| 2021-08-02 | Sale | ARMISTICE CAPITAL, LLC | 10 percent owner | 192,775 1.8717% | $2.40 | $463,046 | -69.80% | |
| 2021-07-30 | Sale | ARMISTICE CAPITAL, LLC | 10 percent owner | 68,188 0.7096% | $2.69 | $183,562 | -70.83% | |
| 2021-07-29 | Sale | ARMISTICE CAPITAL, LLC | 400,000 4.0311% | $3.00 | $1.2M | -74.57% | ||
| 2021-07-28 | Sale | ARMISTICE CAPITAL, LLC | 375,443 3.7408% | $3.28 | $1.23M | -76.79% | ||
| 2021-07-27 | Sale | ARMISTICE CAPITAL, LLC | 2.38M 31.3018% | $5.09 | $12.11M | -79.90% | ||
| 2021-01-06 | ARMISTICE CAPITAL, LLC | 1.53M 21.542% | $5.22 | $8M | -32.02% | |||
| 2020-02-10 | ARMISTICE CAPITAL, LLC | 12,000 0.2683% | $6.04 | $72,480 | -18.43% | |||
| 2020-02-06 | ARMISTICE CAPITAL, LLC | 11,000 0.2463% | $6.18 | $67,980 | -20.16% | |||
| 2019-12-06 | Sale | GOLDBERG MORTON | director | 1,961 0.0619% | $6.93 | $13,590 | -27.54% | |
| 2019-11-12 | Sale | GOLDBERG MORTON | director | 2,001 0.06% | $4.29 | $8,584 | +12.00% |
| IPSA (INNOVEN PARTENAIRES S.A.) | 10 percent owner | 1460479 33.0097% | $2.53M | 1 | 0 | |
| Ventech Capital II | 10 percent owner | 1431814 32.3618% | $2.48M | 1 | 6 | |
| FROM STEPHEN | President and CEO | 1032465 23.3358% | $1.79M | 4 | 3 | |
| ARMISTICE CAPITAL, LLC | 10 percent owner | 785000 17.7426% | $1.36M | 31 | 5 | |
| Romano Sarah | Chief Financial Officer | 262113 5.9243% | $453,455.49 | 3 | 3 | |
| Garanzini Michael | Chief Commercial Officer | 171250 3.8706% | $296,262.50 | 1 | 0 | |
| Strem Brian M. | President and CEO | 14531 0.3284% | $25,138.63 | 2 | 0 | <0.0001% |
| Tosca Melissa | CFO | 13599 0.3074% | $23,526.27 | 2 | 0 | <0.0001% |
| Daniels Eric Joseph | Chief Development Officer | 11222 0.2536% | $19,414.06 | 1 | 0 | <0.0001% |
| CHANEY PAUL G | director | 8333 0.1883% | $14,416.09 | 1 | 0 | |
| Parsons Erin | director | 5260 0.1189% | $9,099.80 | 1 | 0 | <0.0001% |
| TYLE PRAVEEN | director | 5014 0.1133% | $8,674.22 | 1 | 0 | <0.0001% |
| Shapiro Aron | director | 3000 0.0678% | $5,190.00 | 1 | 0 | <0.0001% |
| Walters-Hoffert Lisa | director | 1250 0.0283% | $2,162.50 | 1 | 0 | <0.0001% |
| Stengone Carmine N. | director | 1250 0.0283% | $2,162.50 | 1 | 0 | <0.0001% |
$13,664,154 | 40 | -70.35% | $7.05M | |
$29,645,465 | 28 | 8.09% | $6.48M | |
$63,749,694 | 24 | -12.24% | $6.4M | |
$812,698 | 12 | -57.09% | $7.89M | |
$4,146,041 | 11 | -40.86% | $8.55M |
| Increased Positions | 9 | +50% | 189,013 | +30.68% |
| Decreased Positions | 6 | -33.33% | 98,237 | -15.94% |
| New Positions | 4 | New | 91,459 | New |
| Sold Out Positions | 2 | Sold Out | 15,868 | Sold Out |
| Total Postitions | 21 | +16.67% | 706,945 | +14.73% |
| Adar1 Capital Management, Llc | $339.00 | 4.2% | 167,941 | +830 | +0.5% | 2025-09-30 |
| Nantahala Capital Management, Llc | $316.00 | 3.91% | 156,427 | -54,683 | -25.9% | 2025-09-30 |
| Stonepine Capital Management, Llc | $284.00 | 3.52% | 140,598 | -37,402 | -21.01% | 2025-09-30 |
| Citadel Advisors Llc | $90.00 | 1.11% | 44,573 | +44,573 | New | 2025-09-30 |
| Drw Securities, Llc | $74.00 | 0.92% | 36,865 | +36,865 | New | 2025-09-30 |
| Vanguard Group Inc | $42.00 | 0.52% | 20,915 | +20,915 | New | 2025-09-30 |
| Geode Capital Management, Llc | $38.00 | 0.47% | 18,853 | +280 | +1.51% | 2025-09-30 |
| Renaissance Technologies Llc | $25.00 | 0.31% | 12,400 | +12,400 | New | 2025-09-30 |
| Two Sigma Investments, Lp | $24.00 | 0.3% | 11,984 | +11,984 | New | 2025-09-30 |
| Citigroup Inc | $8.00 | 0.1% | 3,884 | +3,849 | +10,997.14% | 2025-09-30 |